IOI’s training and education programmes are designed to support early-and mid-career researchers to advance science, develop insights, and foster interdisciplinary approaches required to address the wide-ranging challenges of AMR.

INEOS Oxbridge Doctoral Initiative

The INEOS Oxbridge Doctoral Initiative on Antimicrobial Resistance is a fully funded DPhil programme that enables selected candidates to study at both Universities of Oxford and Cambridge.

The programme is funded by the IOI for a duration of 3.5 years (fixed term).

3 studentships will be awarded in Oxford (DPhil) and 4 will be awarded in Cambridge (PhD), with students encouraged to train in both Universities. This provides the chance to experience the best of both academic environments and their established networks.


At the heart of the initiative is an ambition to nurture a diverse cohort of outstanding young scientists who will become equipped to deal with the global challenges posed by the rapidly emerging threat from antimicrobial resistance.

Professor Julian Parkhill, University of Cambridge

The programme offers:

  • Immersion in both Universities
    Although registered in either Oxford or Cambridge as their home base, all students will have ample opportunity to spend periods of time as a visitor in the second University, taking part in ongoing collaborations
  • Collaboration
    Each project is distinct and unique for that student, but there will be the opportunity to collaborate with other students and projects within the initiative, with the additional possibility of input from industry.
  • Funding
    Our studentships are fully funded for three and a half years, through the generous support of the Ineos Oxford Institute. This funding covers UK (and international*) University of Cambridge and University of Oxford fees in addition to living costs (stipend), which will be equivalent to the standard Wellcome stipend rate.

*The funding covers UK fees only, however the lead PIs will cover additional costs for international fees for exceptional overseas candidates.

  • Future prospects
    By the time you graduate, you will have acquired skills that are in high demand worldwide. This includes expertise in drug discovery, machine learning and analysis of big data. Such skills will support your future ambitions wherever these take you, including academia, pharma and private-sector companies.

Projects for 2024/2025 academic year:

Applications for 2024-2025 have now closed.